SBP-3264 is a novel, small molecule inhibitor targeting the serine/threonine kinases STK3 and STK4 (MST1/2). It is a valuable research tool for studying the Hippo signaling pathway in both cellular and animal models, particularly in contexts of cell proliferation, apoptosis, and immune regulation.